Industry Blog

14
May 10

Welcome to the New Website

Welcome to the new Hanningfield Process Systems website.  The updated site offers more content, improved navigation and many exciting new features.  Hopefully you will find the site great to use and will enjoy the enhanced browsing experience the new hanningfield.com offers.  The site provides an excellent showcase for our products and services across material conveying, size reduction, powder containment and material handling, and we hope you find the information both interesting and useful.

 

We would like to thank our web design partners ‘Impact Media’ for their incredible effort throughout the duration of this project.

 

We hope you enjoy the new site and look forward to receiving your feedback at info@hanningfield.com.

Tags: , , , , , , , ,
Posted in Hanningfield, News | No Comments »
12
May 10

Greece decrease prices

In Greece it has come to them having to cut prices of their medicines by up to a fifth to help out other places throughout the EU. The pharmaceuticals were re-priced this week which works out at 27% cut for what is the most expensive.

“It will be a big issue for the country. Although it is a relief for the social security system, low prices will fuel parallel trade, so products will go out of the country,” Yannis Chryssospathis, the association’s legal counsel, said in a telephone interview.

The Hellenic Association of Pharmaceutical Companies have explained that they are taking into consideration that they may take legal action.

Tags: , ,
Posted in News, Pharmaceutical | No Comments »
5
May 10

Drug companies deal to save taxpayers $1bn

The PBS (Pharmaceutical Benefits Scheme) is apparently under costs decrease as The Federal Government is alleged to have been in on a deal with a certain drug manufacturers.

The pharmaceutical industry has said to have agreed to decrease an estimated $1 billion on medicine prices because of this scheme, it was also announced that yesterday the government chose to sign a 5 year agreement with further pharmacists that is expected to lower another $1 billion.

Tags: ,
Posted in News, Pharmaceutical | No Comments »
26
Apr 10

Hospira & Javelin Combine.

Pharmaceutical company Hospira Inc. have decided to increase their pain management portfolio by combining with Javelin Pharmaceuticals for $145m.

Javelin will get paid $2.20 a share which averages it out at $145m.

The two companies agreed that Javelin can be lent up to amount of $4.5m to help with managing activities before finalising a merger with Hospira.

Tags: , , , ,
Posted in News, Pharmaceutical | No Comments »
19
Apr 10

Flight ban stops pharmaceutical produce.

It is said today that Pharmaceutical companies could be the worst off over this flight business, as production of pills are not being transferred to where they need to be.

Christopher Snelling, FTA’s head of global supply said: ‘Consumers won’t notice too much difference on consumer goods but it may be a problem for processes in the manufacturing industry.’

‘Flying in components could be a problem for particular factories. And I think they may have happened already in the pharmaceuticals industry.’

It’s estimated that 25 – 30% of exports into Britain are by plane, and the Pharmaceutical companies need their produce as soon as possible. If flights take so long to arrive then many medicines that go by shelf life could expire and become unusable.

Tags: , , , ,
Posted in News, Pharmaceutical | No Comments »
21
Mar 10

Tablets are old, magnetic device is new!

The days of taking tablets to cure a headache could be long gone if a new gadget which is a magnetic stimulating device that you can hold in the palm of your hand is finally produced.

It has been designed to help the pain of migraine by sending magnetic pulses around the head and has been given the description of a ‘portable single pulse transcranial magnetic stimulation device’.

The research is only early on and could change, but the idea sounds good.

Tags: , ,
Posted in News | No Comments »
20
Feb 10

JB Proces - Associate in Sweden.

At Hanningfield we like to have contacts through out the world, and one of our associates is JB Proces

They are based in Sweden and their website is written in Swedish.

So if you ever need anything Pharmaceutically related and your in Sweden, then bookmark this site.

Hanningfield.

Tags: , ,
Posted in Hanningfield, News | No Comments »
1
Feb 10

Vaccinations.

In England alone 400,000 health and social care workers have been given the vaccine against swine flu.

The Health Department claims that there has been and estimated 387,000 people vaccinated and the number of doses given to the priority groups in 3.7 Million which also includes pregnant woman, 132,000 of them and finally including 214,000 children in good health aged 6 months to 5 years old.

Pharmaceutical companies have been shipping the vaccine out.

Tags: , ,
Posted in News | No Comments »
31
Jan 10

National Pandemic Flu Line Closed.

It has been said today that the Pandemic Flu service will be withdrawn as from 11th February but can be restored within 7 days if it is needed.

The phone line & the website will be taken down, and any leaflets ect will be excluded from advertising it. The website holds information about Swine Flu, such as the symptoms and what to do and who to call, as well as the phone line in which you can call to talk to some one with relevant information.

Dr Ridge explains “the antiviral collection points will continue to operate until the end of the flu season (the end of March 2010) but antivirals will only be authorised via health care professionals using either antiviral authorisation vouchers or the right hand side of FP10s”.

Tags: , , , , , , ,
Posted in News | No Comments »
19
Jan 10

Powerful drug for arthritis approved in Scotland.

An arthritis drug that is quite powerful has been approved in Scotland after it was feared it was too expensive for patients in England & Wales.

 

The NICE (National Institute for Health & Clinical Excellence) has said that the drug Tocilizumab was too expensive for people not living in Scotland.

 

The treatment aims an inflammatory signaling molecule to reduce symptoms, used in combination with standard anti-inflammatory drug MTX researchers have discovered that Tocilizumab can improve remission rates for those with arthritis.

 

Leading rheumatologist Professor John Isaacs, from the Institute of Cellular Medicine at the University of Newcastle, said: “This is fantastic news for people in Scotland who suffer from this disabling, life-long disease.

“However, it also highlights the disparities in accessing treatment between Scotland and the rest of the UK.”

Ailsa Bosworth, chief executive of the National Rheumatoid Arthritis Society, which receives support from pharmaceutical companies including Roche, said: “The SMC’s decision provides people with rheumatoid arthritis in Scotland who face a life of pain and potential disability another chance of combating their disease.

“We strongly hope that Nice will revise its draft guidance to ensure that people with rheumatoid arthritis across the country are able to benefit from RoActemra.”

 

 

Tags: , , , , , ,
Posted in News, Pharmaceutical | No Comments »
« Older Entries
Tag Cloud